ZS Pharma Presents Positive Results From HARMONIZE, A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia
November 17, 2014 at 08:03 AM EST
ZS Pharma (Nasdaq: ZSPH), a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic ...